gel-e's Grant - III Round

gel-e raised a round of funding on February 20, 2018. Investors include U.S. Department of Defense.

gel-e, formerly Remedium Technologies, develops and markets biomaterials which effectively achieve hemostasis, i.e. the halting of blood loss.…

Articles about gel-e's Grant - III Round: